FDA Decision Signals New Competition For Some Of The Costliest Drugs

Drugs made from proteins or antibodies are difficult for rival manufacturers to copy. The Food and Drug Administration just approved a copycat drug for cancer patients that shows it can be done.

» E-Mail This

—> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail